Clinical Trial Update: Carboplatin and Gemcitabine Combined With Celecoxib and/or Zileuton in Treating Patients With Advanced Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating carboplatin and gemcitabine with celecoxib and/or zileuton in advanced non-small cell lung cancer has completed. No results are provide…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Celecoxib (Celecoxib)
• Gemcitabine (Gemcitabine)
• Zileuton (zileuton)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Lung Cancer | Phase 2 | Status: COMPLETED